CIDRAP newsletters options
Previous COVID-19 infection was associated with an almost 50% reduced risk of a symptomatic cold.
Rates of events such as all-cause death, heart attack, stroke, and hospitalization for chest pain, heart failure, and respiratory infections were comparable.
Officials reported 36 more detections in mice, as well as 4 more H5N1 positives in cats.
The NASEM emphasizes that long COVID can follow asymptomatic, mild, or severe cases of COVID-19.
The results suggest that children with severe SARS-CoV-2 or MIS-C and severe neurologic disorders may be at high risk for long-term impairment, the authors say.
The company said a combo vaccine might help bridge gaps in vaccine coverage while simplifying vaccination.
The child in India had been exposed to poultry, which are known to carry the virus in multiple countries.
The rate of mechanical ventilation use was also two- to three-fold higher in 2022-2023 compared with prepandemic years.
GARDP will provide Bugworks up to $20 million in financial and technical support to develop BWC0977, a compound that targets difficult-to-treat pathogens.
An analysis of ED visits for pediatric UTIs from 2011 to 2020 found increasing use of first-generation cephalosporins.
One and 6 months after the second vaccine dose, fatigue, malaise, chills, and headache were each tied to 1.4- to 1.6-fold higher neutralizing antibody levels.
The ferrets used in the study had not been exposed to H5N1 avian flu or any influenza viruses before.
Risk factors for long COVID were female sex, young and old age, White and Hispanic race, and unvaccinated status.
New surveillance data from Europe show a significant rise in azithromycin-resistant gonorrhea in 2022, along with the detection of 2 ceftriaxone-resistant samples.
A longitudinal household study found shared C difficile strains in 17 of 28 families, with the infant detected first in most instances.
No safety concerns were reported after Paxlovid use.
GSK said recent studies have shown RSV causes approximately 42,000 annual hospitalizations in adults aged 50 to 59.
Although a 15-day course of Paxlovid was found to be safe, it didn't demonstrate a significant benefit in improving symptoms.
Researchers say the study is the first to provide real-world estimates of nirsevimab effectiveness against severe RSV in PICU patients.
About 38% of patients experiencing stillbirth received a COVID-19 vaccine in pregnancy, compared with 39% of those with live births.
